SCHEMBL22280910

SCHEMBL22280910

Cc1cc(C)c(-c2ccc3c(c2)c2ccc(Oc4ccc5c6ccccc6n6ccnc6c5c4)cc2c2nccn32)c(C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTAFR P25105 1/20 0.33
BTK Q06187 1/20 0.33
DRD1 P21728 4/20 0.33
TNK2 Q07912 8/20 0.32
TACR1 P25103 2/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280689 0.96 TNK2 (0.34) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL22281206 0.95 DRD1 (0.33) KDM4EALDH1A1HPGDPTAFRBTK
SCHEMBL22280913 0.93 PTAFR (0.31) KDM4EALDH1A1HPGDPTAFRBTK
SCHEMBL22281107 0.90 DRD1 (0.33) KDM4EALDH1A1HPGDPTAFRBTK
SCHEMBL22280917 0.90 PDE4A (0.32) ALDH1A1MEN1KMT2ADRD1
SCHEMBL22280691 0.89 TNK2 (0.31) KDM4EALDH1A1HPGDPTAFRBTK
SCHEMBL22280909 0.87 BCHE (0.39) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL22281108 0.86 PDE4A (0.32) ALDH1A1MEN1KMT2ADRD1TNK2
SCHEMBL22281115 0.86 TNK2 (0.37) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL22280716 0.84 MAPT (0.36) KDM4EALDH1A1HPGDMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES EML4, TYR, TYMP KDM4E 1356/4885ALDH1A1 2652/4885HPGD 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.